GlassScriptPhysician profile
Erik D White
NPI 1598743619
$1,115.99
in general payments reported to CMS, 2019-2025
18 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $140 · 2021: $33.10 · 2022: $135 · 2023: $144 · 2024: $237 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $211.99 | 2020-2024 | Xolair |
| Astrazeneca Pharmaceuticals LP | $154.41 | 2019-2025 | Tezspire |
| Genzyme Corporation | $113.54 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $99.74 | 2019-2023 | |
| Kaleo, INC. | $96.43 | 2019-2023 | Auvi-Q |
| Regeneron Healthcare Solutions, INC. | $94.56 | 2019-2025 | Dupixent |
| Csl Behring | $90.10 | 2020-2025 | Hizentra |
| Amgen INC. | $66.87 | 2023-2025 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $32.06 | 2023 | |
| Aimmune Therapeutics, INC. | $23.17 | 2022 | |
| Pharming Healthcare, INC. | $20.65 | 2025 | Ruconest |
| Ars Pharmaceuticals Operations, INC. | $20.25 | 2025 | Neffy |
| Alk-Abello, INC | $17.64 | 2019 | |
| Kedrion Biopharma, INC. | $16.43 | 2024 | Koate, Kedrab, Gammaked |
| Merck Sharp & Dohme LLC | $16.26 | 2024 | Gardasil, Gardasil 9, M-M-R II |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $14.15 | 2019 | |
| Azurity Pharmaceuticals, INC. | $14.00 | 2025 | Alvesco |
| Takeda Pharmaceuticals U.S.A., INC. | $13.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.